EUVIMEDEUVIMED entdecken
Crossref

Post-market individual-report phenotypes after pulsed-field ablation for atrial fibrillation in a food and drug administration database

Joyce Gu, Lucy Zheng, Hsiao-Man Chang, Daniel Yow, Hyungwoo Kim, Samuel Tan

Journal of Interventional Cardiac Electrophysiology · 31.08.2026 · 69 (9) · 3057-3065

DOI: 10.1007/s10840-026-02431-6 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Interventional Cardiac Electrophysiology, online erschienen am 31.08.2026. Verfasst von Joyce Gu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Santa Clara Valley Medical Center, Santa Clara, CA, USA. Hauptthemen laut MEDLINE: Product Surveillance, Postmarketing, Atrial Fibrillation, Catheter Ablation. Die Arbeit nennt 20 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

To characterize individual-case medical device reports submitted to the U.S. Food and Drug Administration Manufacturer and User Facility Device Experience database for commercially available pulsed-field ablation systems during early postmarket use.

Methods

We analyzed reports received from February 1, 2024, through April 30, 2026. Master event, device, patient, patient problem code, device problem code, and narrative files were merged by report key. Literature-derived, clinical study-derived, false-positive, indeterminate, and exact duplicate narrative reports were excluded from the primary individual-case cohort. A prespecified hierarchy and targeted narrative review classified reporting phenotypes, reported clinical event categories, and device problem code categories. Duplicate-removal sensitivity analyses were performed.

Results

Of 11,563 potential reports, 10,976 individual-case reports formed the primary cohort. Device malfunction without identified patient injury accounted for 7,323 reports (66.7%), patient injury for 3,554 (32.4%), and unclear/no coded clinical event for 99 (0.9%). The most commonly reported clinical event categories were tamponade/perforation/pericardial effusion ( n = 1,014), arrhythmia/cardioversion/hemodynamic events ( n = 444), stroke/TIA/neurovascular events ( n = 383), coronary spasm/injury/ischemia ( n = 324), death ( n = 197), hemolysis/renal injury ( n = 114), phrenic/diaphragm injury ( n = 42), and plausible esophageal or upper gastrointestinal concerns ( n = 6). Duplicate removal did not materially change the report-category hierarchy.

Conclusions

The value of this report-level surveillance analysis is characterization of report and event categories rather than incidence estimation. Future pulsed-field ablation registries should capture anticoagulation-related variables, patient-reported outcomes, lesion set and application burden, and adjudicated neurologic, coronary, renal, esophageal, and phrenic outcomes. Capsule Summary PFA MAUDE reports identify electroporation-and workflow-relevant surveillance domains that should be prospectively captured, including anticoagulation variables, patient-reported outcomes, lesion set, application burden, and adjudicated clinical outcomes. Graphical Abstract FDA MAUDE reports after early pulsed-field ablation adoption identify clinically relevant post-market reporting phenotypes and define priorities for prospective PFA surveillance registries.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Product Surveillance, PostmarketingAtrial FibrillationCatheter AblationHumansUnited StatesUnited States Food and Drug AdministrationDatabases, FactualFemalePhenotypeMaleEquipment Failure

Stichwörter der Autor:innen

Atrial fibrillationCatheter ablationElectrophysiologyMedical device safetyPostmarket surveillancePulsed-field ablation

Autor:innen und Institutionen

  • Department of Medicine, Santa Clara Valley Medical Center, Santa Clara, CA, USA.
  • Department of Cardiology, Stony Brook University, New York, USA.
  • Department of Medicine, Mount Sinai Morningside, New York, NY, USA.
  • Department of Medicine, Penn Presbyterian Medical Center, Philadelphia, PA, USA.
  • Department of Cardiology, Mount Sinai Morningside, New York, NY, USA. Samuel.tan@mountsinai.org.
  • Department of Cardiology, James J Peter VA Medical Center, Bronx, USA. Samuel.tan@mountsinai.org.

Zitieren

APA

Gu, J., Zheng, L., Chang, H. M., Yow, D., Kim, H., & Tan, S. (2026). Post-market individual-report phenotypes after pulsed-field ablation for atrial fibrillation in a food and drug administration database. Journal of Interventional Cardiac Electrophysiology, 69(9), 3057-3065. https://doi.org/10.1007/s10840-026-02431-6

Vancouver

Gu J, Zheng L, Chang HM, Yow D, Kim H, Tan S. Post-market individual-report phenotypes after pulsed-field ablation for atrial fibrillation in a food and drug administration database. Journal of Interventional Cardiac Electrophysiology. 2026;69(9):3057-3065. doi:10.1007/s10840-026-02431-6

BibTeX
@article{Gu2026,
  author = {Gu, Joyce and Zheng, Lucy and Chang, Hsiao-Man and Yow, Daniel and Kim, Hyungwoo and Tan, Samuel},
  title = {Post-market individual-report phenotypes after pulsed-field ablation for atrial fibrillation in a food and drug administration database},
  journal = {Journal of Interventional Cardiac Electrophysiology},
  year = {2026},
  volume = {69},
  number = {9},
  pages = {3057--3065},
  doi = {10.1007/s10840-026-02431-6}
}
Kostenlos starten →